Antimicrobial resistance (AMR) is a global health crisis that threatens lives, communities, and the sustainability of health systems.
From 18 - 20 February in Sydney, join global leaders from health, finance, policy, and science sectors to drive real sustainable solutions to protect people and the planet. Hosted by the Fleming Initiative and CSIRO, the AMR2026 Summit isn't just another conference; it's a carefully curated, prestigious event designed to support action and innovation that reduces risk, improves health and wellbeing, and creates long-term value for communities, countries, and investors.
In addition, on day 1 of the conference, we are also planning an investor side event where attendees will explore why antimicrobial resistance (AMR) is a systemic risk that investors need to manage and mitigate.
The aim is to connect experts and investors for a hands-on workshop that explores why AMR is gaining global attention and the threats and opportunities it presents for investors. Participants will gain actionable insights on how to integrate AMR considerations into their investment decision-making and stewardship practices.
We need your help to ensure this special session meets the needs of those planning to attend. Please fill out this form indicating your preferences.
Key Information
| Date: | 18 February - 20 February 2026 |
| Time: | 00:00 - 00:00 AEST (UTC+10) |
| Location: | Sydney, Australia |
| Address: | Sheraton Grand Sydney Hyde Park Sydney, Australia |